Adoptive cell transfer in autoimmune hepatitis

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Expert Review of Gastroenterology & Hepatology

• Publication date

  2015-05-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1586/17474124.2015.1019470PMID 25719553
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tolerogenic dendritic cells

  2016cited by this paper
• Caveats of mesenchymal stem cell therapy in solid organ transplantation

  2015cited by this paper
• Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study

  2014cited by this paper
• CTLA-4 Modulates the Differentiation of Inducible Foxp3+ Treg Cells but IL-10 Mediates Their Function in Experimental Autoimmune Encephalomyelitis

  2014cited by this paper
• Genome-wide association study identifies variants associated with autoimmune hepatitis type 1.

  2014cited by this paper
• Regulatory T Cells as Immunotherapy

  2014influential reference
• Myeloid-Derived Suppressor Cells as a Potential Therapy for Experimental Autoimmune Myasthenia Gravis

  2014cited by this paper
• The Role of Dendritic Cells in Tissue-Specific Autoimmunity

  2014influential reference
• Current and prospective pharmacotherapy for autoimmune hepatitis

  2014cited by this paper
• Regulatory T-cell therapy in the induction of transplant tolerance: the issue of subpopulations.

  2014cited by this paper
• Retinoic acid stabilizes antigen-specific regulatory T-cell function in autoimmune hepatitis type 2.

  2014cited by this paper
• Use of gene-modified regulatory T-cells to control autoimmune and alloimmune pathology: is now the right time?

  2014influential reference
• Intractable diseases treated with intra-bone marrow-bone marrow transplantation

  2014cited by this paper
• Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages

  2014cited by this paper
• Rationale for the potential use of mesenchymal stromal cells in liver transplantation.

  2014influential reference
• Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3+ regulatory T cells

  2014influential reference
• Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy.

  2014influential reference
• Adoptive transfer of human gingiva-derived mesenchymal stem cells ameliorates collagen-induced arthritis via suppression of Th1 and Th17 cells and enhancement of regulatory T cell differentiation.

  2013cited by this paper
• Gastro-intestinal autoimmunity: preclinical experiences and successful therapy of fistulizing bowel diseases and gut Graft versus host disease by mesenchymal stromal cells

  2013influential reference
• A Mouse Model of Adoptive Immunotherapeutic Targeting of Autoimmune Arthritis Using Allo-Tolerogenic Dendritic Cells

  2013influential reference
• Human Mesenchymal Stem Cells Provide Protection against Radiation-Induced Liver Injury by Antioxidative Process, Vasculature Protection, Hepatocyte Differentiation, and Trophic Effects

  2013cited by this paper
• Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation

  2013cited by this paper
• Use of Mesenchymal Stem Cells (MSC) in Chronic Inflammatory Fistulizing and Fibrotic Diseases: a Comprehensive Review

  2013influential reference
• PPARγ Agonists in Adaptive Immunity: What Do Immune Disorders and Their Models Have to Tell Us?

  2013cited by this paper
• Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance

  2013influential reference
• Cellular and molecular interactions of mesenchymal stem cells in innate immunity

  2013cited by this paper
• Splenectomy prolongs the effects of corticosteroids in mouse models of autoimmune hepatitis.

  2013cited by this paper
• Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis

  2013cited by this paper
• Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis

  2013influential reference
• Donor-Derived Mesenchymal Stem Cells Combined With Low-Dose Tacrolimus Prevent Acute Rejection After Renal Transplantation: A Clinical Pilot Study

  2013cited by this paper
• Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?

  2013cited by this paper
• Mesenchymal Stem Cells Alleviate Bacteria-Induced Liver Injury in Mice by Inducing Regulatory Dendritic Cells

  2013cited by this paper
• Bortezomib modulates regulatory T cell subpopulations in the process of acute graft-versus-host disease.

  2013cited by this paper
• Reply to: “Regulatory T cells in autoimmune hepatitis”

  2012influential reference
• Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion

  2012cited by this paper
• Multipotent Mesenchymal Stromal Cell Therapy and Risk of Malignancies

  2012cited by this paper
• Regulatory T cells in autoimmune hepatitis.

  2012influential reference
• Immunomodulatory Effect of Mesenchymal Stem Cells on B Cells

  2012cited by this paper
• Immunotherapy of Malignant Disease Using Chimeric Antigen Receptor Engrafted T Cells

  2012cited by this paper
• FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency.

  2012influential reference
• Adoptive Transfer of Immunomodulatory M2 Macrophages Prevents Type 1 Diabetes in NOD Mice

  2012influential reference
• Inhibition of interleukin-17 promotes differentiation of CD25⁻ cells into stable T regulatory cells in patients with autoimmune hepatitis.

  2012cited by this paper
• Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases?

  2012influential reference
• CD4(+)Foxp3(+) regulatory T cell therapy in transplantation.

  2012cited by this paper
• The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin‐9/tim‐3 pathway

  2012cited by this paper
• Stable antigen‐specific T‐cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients

  2012cited by this paper
• Drug choices in autoimmune hepatitis: Part B – nonsteroids

  2012cited by this paper
• Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial.

  2012cited by this paper
• Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study.

  2011cited by this paper
• Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease

  2011cited by this paper
• Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol

  2011influential reference
• Autoantigen‐specific regulatory T cells, a potential tool for immune‐tolerance reconstitution in type‐2 autoimmune hepatitis

  2011cited by this paper
• Mesenchymal stem cells: from experiment to clinic

  2011cited by this paper
• Antigen-Specific TGF-β–Induced Regulatory T Cells Secrete Chemokines, Regulate T Cell Trafficking, and Suppress Ongoing Autoimmunity

  2011cited by this paper
• Dendritic cell control of tolerogenic responses

  2011influential reference
• Phase I (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic Patients

  2011cited by this paper
• Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells

  2011cited by this paper
• Malignant Tumor Formation After Transplantation of Short-Term Cultured Bone Marrow Mesenchymal Stem Cells in Experimental Myocardial Infarction and Diabetic Neuropathy

  2011cited by this paper
• Glucocorticosteroids Modify Langerhans Cells To Produce TGF-β and Expand Regulatory T Cells

  2011cited by this paper
• Regulatory T-cell adoptive immunotherapy: potential for treatment of autoimmunity

  2011cited by this paper
• Mouse Bone Marrow-Derived Mesenchymal Stromal Cells Turn Activated Macrophages into a Regulatory-Like Profile

  2010cited by this paper
• Diagnosis and management of autoimmune hepatitis

  2010cited by this paper
• Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study.

  2010cited by this paper
• Cannabinoid receptor activation leads to massive mobilization of myeloid‐derived suppressor cells with potent immunosuppressive properties

  2010cited by this paper
• Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory Cells

  2010cited by this paper
• Much Ado about Adenosine: Adenosine Synthesis and Function in Regulatory T Cell Biology

  2010cited by this paper
• Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function

  2010cited by this paper
• Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis.

  2010cited by this paper
• Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation.

  2010cited by this paper
• Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study

  2010cited by this paper
• Defining the risks of mesenchymal stromal cell therapy.

  2010cited by this paper
• Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track - letter.

  2010cited by this paper
• Tolerogenic Dendritic Cells Generated with Different Immunosuppressive Cytokines Induce Antigen-Specific Anergy and Regulatory Properties in Memory CD4+ T Cells

  2010cited by this paper
• A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis

  2010cited by this paper
• The costimulatory role of TIM molecules

  2009cited by this paper
• Amelioration of colitis by genetically engineered murine regulatory T cells redirected by antigen-specific chimeric receptor.

  2009cited by this paper
• Human mesenchymal stem cells and immunosuppressive drug interactions in allogeneic responses: an in vitro study using human cells.

  2009cited by this paper
• Use of epigenetic modification to induce FOXP3 expression in naïve T cells.

  2009cited by this paper
• Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages.

  2009cited by this paper
• Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions

  2009cited by this paper
• Is antigen specificity of autoreactive T cells the key to islet entry?

  2009cited by this paper
• Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling

  2009influential reference
• Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10

  2009influential reference
• Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo

  2009influential reference
• Monotherapy rapamycin allows an increase of CD4+ CD25bright+ FoxP3+ T cells in renal recipients

  2009cited by this paper
• Species Variation in the Mechanisms of Mesenchymal Stem Cell‐Mediated Immunosuppression

  2009cited by this paper
• Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue.

  2009cited by this paper
• Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the TH17 lineage-specific transcription factor RORγt

  2009influential reference
• Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation.

  2009cited by this paper
• Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T‐cells

  2009influential reference
• CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis1

  2009cited by this paper
• Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis

  2009influential reference
• Dendritic cells modulated by innate immunity improve collagen‐induced arthritis and induce regulatory T cells in vivo

  2009cited by this paper
• Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

  2008cited by this paper
• Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium.

  2008cited by this paper
• Transforming growth factor‐β1‐induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus‐like syndrome of chronic graft‐versus‐host disease

  2008cited by this paper
• Adoptive cell transfer: a clinical path to effective cancer immunotherapy

  2008cited by this paper
• Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes

  2008cited by this paper
• CD4+FoxP3+ regulatory T cells confer infectious tolerance in a TGF-β–dependent manner

  2008influential reference
• The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes

  2008cited by this paper

• Hydrogels in the Immune Context: In Vivo Applications for Modulating Immune Responses in Cancer Therapy

  2025cites this paper
• A lncRNA Dleu2-encoded peptide relieves autoimmunity by facilitating Smad3-mediated Treg induction

  2024cites this paper
• The imbalance of liver resident macrophages polarization promotes chronic autoimmune hepatitis development in mice

  2023cites this paper
• Myeloid-derived suppressor cells as cellular immunotherapy in transplantation and autoimmune diseases.

  2021cites this paper
• The Immunological Mechanisms and Immune-Based Biomarkers of Drug-Induced Liver Injury

  2021influential citation
• Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis

  2020cites this paper
• Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases

  2019cites this paper
• Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions

  2019cites this paper
• Synthetic Biology in Immunotherapy and Stem Cell Therapy Engineering

  2018cites this paper
• Crosstalk between mesenchymal stem cells and T regulatory cells is crucially important for the attenuation of acute liver injury

  2018cites this paper
• Review article: next‐generation transformative advances in the pathogenesis and management of autoimmune hepatitis

  2017cites this paper
• Evolving paradigm of treatment for autoimmune hepatitis

  2017cites this paper
• Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions

  2016influential citation